Search Orphan Drug Designations and Approvals
-
Generic Name: | Tissue Plasminogen activator |
---|---|
Date Designated: | 04/18/2011 |
Orphan Designation: | Treatment of acute ischemic stroke (AIS) in children age 16 years and younger. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Catherine Amlie-Lefond, MD University of Washington 4800 Sand Point Way NE - M/S B5552 Seattle, Washington 98105 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-